Juno Therapeutics, Inc. (NASDAQ:JUNO) Consolidated Diluted EPS At -2.7157

0

For the year ended 2015-12-31 Juno Therapeutics, Inc. (NASDAQ:JUNO) basic consolidated EPS came $-2.7157. In addition, for the quarter closed 2015-12-31, it was $-2.7157.

EPS from continuing operations

Juno Therapeutics, Inc. (NASDAQ:JUNO) EPS from continuing activities was $-2.7157 for the fiscal ended 2015-12-31. For the quarter ended 2015-12-31, this figure was $-2.7157.

Basic net EPS

Juno Therapeutics, Inc. (NASDAQ:JUNO) basic net EPS was $-2.72 for the year ended 2015-12-31. For the quarter ended 2015-12-31, it came at $-2.72.

Consolidated diluted EPS

Juno Therapeutics, Inc. (NASDAQ:JUNO) consolidated diluted EPS was -2.7157 for the year ended 2015-12-31. For the quarter ended 2015-12-31, it stood at $-2.7157.

EPS contribution from parent

Juno Therapeutics, Inc. (NASDAQ:JUNO) basic EPS was $-2.7157 for the year ended 2015-12-31 from its parent group. It was $-2.7157 for the quarter closed 2015-12-31.

Diluted EPS from parent

Juno Therapeutics, Inc. (NASDAQ:JUNO) diluted EPS from parent firm came at $-2.7157 for the year ended 2015-12-31. For the quarter ended 2015-12-31 it was $-2.7157.

Basic diluted EPS

Juno Therapeutics, Inc. (NASDAQ:JUNO) basic diluted EPS was $-0.7164 for the quarter ended 2015-12-31. For the year ended 2015-12-31, basic diluted EPS was $-0.7164.

Net diluted EPS

Juno Therapeutics, Inc. (NASDAQ:JUNO) net diluted EPS was $-2.72 for the fiscal closed 2015-12-31. For the quarter ended 2015-12-31, net diluted EPS was $-2.72.

Juno Therapeutics, Inc. (NASDAQ:JUNO) net basic EPS was $-36.82 for the year ended 2015-12-31. For the quarter ended 2015-12-31, it was $-36.82.

For the year ended 2015-12-31, basic shares outstanding were 8.443 while for the quarter ended 2015-12-31 is 8.443.

For the fiscal ended 2015-12-31, the diluted outstanding shares were 8.443 and for the quarter ended 2015-12-31 it was 8.443.

1 Chart Pattern Every Investor Should Know

This little-known pattern preceded moves of 578% in ARWR, 562% in LCI, 513% in ICPT, 439% in EGRX, 408% in ADDUS and more...

Click Here to See This Now.

(Visited 4 times, 1 visits today)